GIS:NYSEGeneral Mills, Inc. Analysis
Data as of 2026-08-30 - not real-time
$41.55
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
General Mills, Inc. is priced at $41.55, and its moving averages give no clean directional read — the structure is neutral. It has gained 9.4% over the past 30 days. Momentum indicators put RSI at 67.2 (approaching overbought) with MACD reading bullish. Watch $35.39 as support and $41.67 as the nearer resistance level.
On valuation the read is overvalued — an earnings multiple of 12.9, absent a reliable peer benchmark. Analyst price targets sit 9.6% below the current price. Revenue is growing at 2.2% on a -0.5% profit margin. The 6.03% dividend yield looks covered by current payout levels.
Risk comes out at 5 of a possible 10, a moderate reading. With 30-day volatility of 32.3%, a beta of -0.29 and a maximum drawdown of 37.1%, position sizing matters here. The wider market backdrop reads extreme greed at 96 on the fear-greed composite.
The horizons diverge: hold near-term but sell on a long view, at 4/10 conviction over the longer horizon.
On valuation the read is overvalued — an earnings multiple of 12.9, absent a reliable peer benchmark. Analyst price targets sit 9.6% below the current price. Revenue is growing at 2.2% on a -0.5% profit margin. The 6.03% dividend yield looks covered by current payout levels.
Risk comes out at 5 of a possible 10, a moderate reading. With 30-day volatility of 32.3%, a beta of -0.29 and a maximum drawdown of 37.1%, position sizing matters here. The wider market backdrop reads extreme greed at 96 on the fear-greed composite.
The horizons diverge: hold near-term but sell on a long view, at 4/10 conviction over the longer horizon.
Top Market Events
The Kraft Heinz Company NASDAQ:KHC and General Mills, Inc.General Mills stock has had a weak run over the past few years, while current valuation checks suggest the shares are...General Mills NYSE: GIS has put forward a proposal to amend its bylaws to address officer exculpation and a federal...
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 1/10
Key Factors
- Trading above the 200-day average of 40.08
- MACD momentum is positive
- 30-day price change of +9.4%
Medium Term
1–3 yearsNeutral
Model confidence: 3/10
Key Factors
- Trading above the 200-day average of 40.08
- Analyst targets imply -9.6% versus the current price
- MACD momentum is positive
Long Term
> 3 yearsCautious
Model confidence: 4/10
Key Factors
- Negative profit margin of -0.5%
- Analyst targets imply -9.6% versus the current price
- Negative return on equity of -1.0%
Key Metrics & Analysis
Financial Health
Revenue Growth2.20%
Profit Margin-0.47%
P/E Ratio12.9
ROE-1.03%
ROA5.74%
Debt/Equity217.63
P/B Ratio4.0
Op. Cash Flow$2.2B
Free Cash Flow$2.3B
Technical Analysis
TrendNeutral
RSI67.2
Support$35.39
Resistance$41.67
MA 20$38.55
MA 50$37.22
MA 200$40.08
MACDBullish
VolumeStable
Fear & Greed Index95.66
Valuation
Fair Value$61.69
Target Price$37.56
Upside/Downside-9.61%
GradeOvervalued
TypeValue
Dividend Yield6.03%
Risk Assessment
Beta-0.29
Volatility32.27%
Sector RiskLow
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.